Our new review on current progress current progress in structural biology & medicinal chemistry of Plasmepsin-II and its inhibitors has been accepted in European Journal of Medicinal Chemistry (Impact Factor: 3.43). The review entitled ” New paradigm of an old target: an update on structural biology and current progress in drug design towards Plasmepsin II”is also the paper of Nirnoy Dan who is currently pursuing his B.Pharm from Birla Institute of Technology, Mesra, India.